Haleon HLN
NYSE HLN
$9.89 +0.02 (+0.15%)
At close: Aug 20, 2026 · 3:00 PM UTC

Haleon (HLN) EBT Growth (1y) (2022 - 2023)

Haleon (HLN) EBT Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -
2 Teva Pharmaceutical Industries 43.00 Bn 39.35 Bn 2.15 Bn -324.14%
3 Zoetis 31.60 Bn 29.93 Bn 1.05 Bn -5.04%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -1.93%
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn -8.74%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 70.52%
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn 1.69%
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn 124.00%
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn -101.79%

Historic Data

Download Data
DateValue
Dec 31, 2023 13.37%
Dec 31, 2022 -4.87%